Alzheimer's Disease in Adults with Down Syndrome

Overview

Journal Int Rev Res Ment Retard

Date 2011 Sep 28

PMID 19633729

Citations 44

Authors

Warren B Zigman

Darlynne A Devenny

Sharon J Krinsky-McHale

Edmund C Jenkins

Tiina K Urv

Jerzy Wegiel

Nicole Schupf

Wayne Silverman

Affiliations

Soon will be listed here.

Citing Articles

The Incidence and Prevalence of Dementia Among Ontario Adults With and Without Intellectual and Developmental Disabilities.

Patel P, Sun W, Mataruga A, Fung K, Balogh R Int J Geriatr Psychiatry. 2025; 40(2):e70050.

PMID: 39939115 PMC: 11821373. DOI: 10.1002/gps.70050.

Validity of one-time assessments for identifying prodromal Alzheimer's disease in adults with Down syndrome.

Krinsky-McHale S, Kovacs C, Lee J, Listwan T, Pang D, Schupf N Alzheimers Dement (Amst). 2025; 17(1):e70076.

PMID: 39935890 PMC: 11812125. DOI: 10.1002/dad2.70076.

A neuropathology case report of a woman with Down syndrome who remained cognitively stable: Implications for resilience to neuropathology.

Liou J, Lou J, Flores-Aguilar L, Nakagiri J, Yong W, Hom C Alzheimers Dement. 2025; 21(2):e14479.

PMID: 39868632 PMC: 11851131. DOI: 10.1002/alz.14479.

Association of plasma neurofilament light chain with microstructural white matter changes in Down syndrome.

Rosas H, Mercaldo N, Hasimoglu Y, Petersen M, Lewis L, Lai F Alzheimers Dement (Amst). 2024; 16(4):e70023.

PMID: 39583646 PMC: 11582681. DOI: 10.1002/dad2.70023.

Single-Nucleus Profiling Identifies Accelerated Oligodendrocyte Precursor Cell Senescence in a Mouse Model of Down Syndrome.

Rusu B, Kukreja B, Wu T, Dan S, Feng M, Kalish B eNeuro. 2023; 10(8).

PMID: 37491366 PMC: 10449487. DOI: 10.1523/ENEURO.0147-23.2023.

References

Edland S, Rocca W, Petersen R, Cha R, Kokmen E . Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol. 2002; 59(10):1589-93. DOI: 10.1001/archneur.59.10.1589. View

Zandi P, Sparks D, Khachaturian A, Tschanz J, Norton M, Steinberg M . Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry. 2005; 62(2):217-24. DOI: 10.1001/archpsyc.62.2.217. View

Hoshino T, Kamino K, Matsumoto M . Gene dose effect of the APOE-epsilon4 allele on plasma HDL cholesterol level in patients with Alzheimer's disease. Neurobiol Aging. 2002; 23(1):41-5. DOI: 10.1016/s0197-4580(01)00252-4. View

Crome L . Morphological aspects of mental retardation. Proc R Soc Med. 1972; 65(7):587-8. PMC: 1644233. View

Reiss S . Development of a psychopathology rating scale for children with mental retardation. J Consult Clin Psychol. 1994; 62(1):28-33. DOI: 10.1037//0022-006x.62.1.28. View

Lesko L, Atkinson Jr A . Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol. 2001; 41:347-66. DOI: 10.1146/annurev.pharmtox.41.1.347. View

Ryoo S, Jeong H, Radnaabazar C, Yoo J, Cho H, Lee H . DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease. J Biol Chem. 2007; 282(48):34850-7. DOI: 10.1074/jbc.M707358200. View

Isbir T, Agachan B, Yilmaz H, Aydin M, Kara I, Eker E . Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease. Am J Alzheimers Dis Other Demen. 2001; 16(2):77-81. PMC: 10833945. DOI: 10.1177/153331750101600207. View

Albert M, Cohen C . The Test for Severe Impairment: an instrument for the assessment of patients with severe cognitive dysfunction. J Am Geriatr Soc. 1992; 40(5):449-53. DOI: 10.1111/j.1532-5415.1992.tb02009.x. View

10.

Zigman W, Schupf N, Devenny D, Miezejeski C, Ryan R, Urv T . Incidence and prevalence of dementia in elderly adults with mental retardation without down syndrome. Am J Ment Retard. 2004; 109(2):126-41. DOI: 10.1352/0895-8017(2004)109<126:IAPODI>2.0.CO;2. View

11.

Sparks D, Sabbagh M, Connor D, Lopez J, Launer L, Browne P . Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol. 2005; 62(5):753-7. DOI: 10.1001/archneur.62.5.753. View

12.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

13.

Blennow K, Hampel H . CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2003; 2(10):605-13. DOI: 10.1016/s1474-4422(03)00530-1. View

14.

Schupf N, Sergievsky G . Genetic and host factors for dementia in Down's syndrome. Br J Psychiatry. 2002; 180:405-10. DOI: 10.1192/bjp.180.5.405. View

15.

Prasher V, Farrer M, Kessling A, Fisher E, West R, Barber P . Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann Neurol. 1998; 43(3):380-3. DOI: 10.1002/ana.410430316. View

16.

Devenny D, Wegiel J, Schupf N, Jenkins E, Zigman W, Krinsky-McHale S . Dementia of the Alzheimer's type and accelerated aging in Down syndrome. Sci Aging Knowledge Environ. 2005; 2005(14):dn1. DOI: 10.1126/sageke.2005.14.dn1. View

17.

Manly J, Schupf N, Tang M, Stern Y . Cognitive decline and literacy among ethnically diverse elders. J Geriatr Psychiatry Neurol. 2005; 18(4):213-7. DOI: 10.1177/0891988705281868. View

18.

Wisniewski K, Wisniewski H, Wen G . Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol. 1985; 17(3):278-82. DOI: 10.1002/ana.410170310. View

19.

Silverman W, Schupf N, Zigman W, Devenny D, Miezejeski C, Schubert R . Dementia in adults with mental retardation: assessment at a single point in time. Am J Ment Retard. 2004; 109(2):111-25. DOI: 10.1352/0895-8017(2004)109<111:DIAWMR>2.0.CO;2. View

20.

Schupf N, Kapell D, Lee J, Zigman W, Canto B, Tycko B . Onset of dementia is associated with apolipoprotein E epsilon4 in Down's syndrome. Ann Neurol. 1996; 40(5):799-801. DOI: 10.1002/ana.410400518. View